BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34638082)

  • 1. 3D MR fingerprinting (MRF) for simultaneous T1 and T2 quantification of the bone metastasis: Initial validation in prostate cancer patients.
    Choi MH; Lee SW; Kim HG; Kim JY; Oh SW; Han D; Kim DH
    Eur J Radiol; 2021 Nov; 144():109990. PubMed ID: 34638082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.
    Lee YS; Choi MH; Lee YJ; Han D; Kim DH
    Br J Radiol; 2022 Mar; 95(1131):20210479. PubMed ID: 34415785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.
    Shiradkar R; Panda A; Leo P; Janowczyk A; Farre X; Janaki N; Li L; Pahwa S; Mahran A; Buzzy C; Fu P; Elliott R; MacLennan G; Ponsky L; Gulani V; Madabhushi A
    Eur Radiol; 2021 Mar; 31(3):1336-1346. PubMed ID: 32876839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.
    Panda A; OʼConnor G; Lo WC; Jiang Y; Margevicius S; Schluchter M; Ponsky LE; Gulani V
    Invest Radiol; 2019 Aug; 54(8):485-493. PubMed ID: 30985480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Analysis of Prostate MRI: Correlation between Contrast-Enhanced Magnetic Resonance Fingerprinting and Dynamic Contrast-Enhanced MRI Parameters.
    Choi MH; Lee YJ; Han D; Kim DH
    Curr Oncol; 2023 Dec; 30(12):10299-10310. PubMed ID: 38132384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Novel Three-Dimensional Magnetic Resonance Fingerprinting of the Prostate Gland: Phantom and Clinical Studies.
    Han D; Choi MH; Lee YJ; Kim DH
    Korean J Radiol; 2021 Aug; 22(8):1332-1340. PubMed ID: 34047506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial assessment of 3D magnetic resonance fingerprinting (MRF) towards quantitative brain imaging for radiation therapy.
    Lu L; Chen Y; Shen C; Lian J; Das S; Marks L; Lin W; Zhu T
    Med Phys; 2020 Mar; 47(3):1199-1214. PubMed ID: 31834641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
    Cui Y; Han S; Liu M; Wu PY; Zhang W; Zhang J; Li C; Chen M
    J Magn Reson Imaging; 2020 Aug; 52(2):552-564. PubMed ID: 32027071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric quantification of T1 and T2 relaxation time of bone metastasis in comparison with red or fatty bone marrow using magnetic resonance fingerprinting.
    Byun H; Han D; Chun HJ; Lee SW
    Skeletal Radiol; 2024 Jun; 53(6):1071-1080. PubMed ID: 38041749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeatability of MR fingerprinting in normal cervix and utility in cervical carcinoma.
    Wang M; Perucho JAU; Cao P; Vardhanabhuti V; Cui D; Wang Y; Khong PL; Hui ES; Lee EYP
    Quant Imaging Med Surg; 2021 Sep; 11(9):3990-4003. PubMed ID: 34476184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of magnetic resonance fingerprinting to differentiate grade I transitional and fibrous meningiomas from meningothelial meningiomas.
    Zhang R; Shen Y; Bai Y; Zhang X; Wei W; Lin R; Feng Q; Wang M; Zhang M; Nittka M; Koerzdoerfer G; Wang M
    Quant Imaging Med Surg; 2021 Apr; 11(4):1447-1457. PubMed ID: 33816181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance fingerprinting based comprehensive quantification of T1 and T2 values of the background prostatic peripheral zone: Correlation with clinical and demographic features.
    de Oliveira Correia ET; Qiao PL; Griswold MA; Chen Y; Bittencourt LK
    Eur J Radiol; 2023 Jul; 164():110883. PubMed ID: 37209463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR Fingerprinting-A Radiogenomic Marker for Diffuse Gliomas.
    Springer E; Cardoso PL; Strasser B; Bogner W; Preusser M; Widhalm G; Nittka M; Koerzdoerfer G; Szomolanyi P; Hangel G; Hainfellner JA; Marik W; Trattnig S
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative longitudinal mapping of radiation-treated prostate cancer using MR fingerprinting with radial acquisition and subspace reconstruction.
    Yu VY; Otazo R; Wu C; Subashi E; Baumann M; Koken P; Doneva M; Mazurkewitz P; Shasha D; Zelefsky M; Cervino L; Cohen O
    Magn Reson Imaging; 2023 Sep; 101():25-34. PubMed ID: 37015305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-Dimensional Magnetic Resonance Fingerprinting in Neonates: Quantifying Regional Difference and Maturation in the Brain.
    Yu N; Kim JY; Han D; Kim SY; Lee HM; Kim DH; Kim HG
    Invest Radiol; 2022 Jan; 57(1):44-51. PubMed ID: 34101674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstruction of multi-phase parametric maps in 4D-magnetic resonance fingerprinting (4D-MRF) by optimization of local T1 and T2 sensitivities.
    Wong YL; Li T; Liu C; Lee HV; Cheung LA; Hui ESK; Cao P; Cai J
    Med Phys; 2024 Feb; ():. PubMed ID: 38386904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.
    Yu AC; Badve C; Ponsky LE; Pahwa S; Dastmalchian S; Rogers M; Jiang Y; Margevicius S; Schluchter M; Tabayoyong W; Abouassaly R; McGivney D; Griswold MA; Gulani V
    Radiology; 2017 Jun; 283(3):729-738. PubMed ID: 28187264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T
    Gerhalter T; Cloos M; Chen AM; Dehkharghani S; Peralta R; Babb JS; Zarate A; Bushnik T; Silver JM; Im BS; Wall S; Baete S; Madelin G; Kirov II
    Eur Radiol; 2022 Feb; 32(2):1308-1319. PubMed ID: 34410458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
    Park S; Park JG; Jun S; Kim H; Kim TS; Kang H
    Magn Reson Imaging; 2020 Nov; 73():118-124. PubMed ID: 32860869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Magnetic Resonance Fingerprinting: Technical Developments and Initial Clinical Validation.
    Cruz G; Jaubert O; Botnar RM; Prieto C
    Curr Cardiol Rep; 2019 Jul; 21(9):91. PubMed ID: 31352620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.